Samsung Biologics Co.,Ltd. current ratio

The Current Ratio as of October 2026 (TTM) for Samsung Biologics Co.,Ltd. (207940.KS) is 1.80

According to Samsung Biologics Co.,Ltd.’s latest financial reports and current stock price. The company's current Current Ratio is 1.80. This represents a change of 37.23% compared to the average of 1.31 of the last 4 quarters.

Samsung Biologics Co.,Ltd. (207940.KS) Historical Current Ratio (quarterly & annually)

How has 207940.KS Current Ratio performed in the past?

The mean historical Current Ratio of Samsung Biologics Co.,Ltd. over the last ten years is 1.66. The current 1.80 Current Ratio has changed 8.20% with respect to the historical average. Over the past ten years (40 quarters), 207940.KS's Current Ratio was at its highest in in the June 2021 quarter at 3.34. The Current Ratio was at its lowest in in the September 2026 quarter at 0.

Samsung Biologics Co.,Ltd. (207940.KS) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Samsung Biologics Co.,Ltd. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Samsung Biologics Co.,Ltd. (207940.KS) Average Current Ratio

How has 207940.KS Current Ratio performed in the past?

The current Current Ratio of Samsung Biologics Co.,Ltd. (207940.KS) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Samsung Biologics Co.,Ltd. (207940.KS) Current Ratio vs. Peers

How is 207940.KS’s Current Ratio compared to its peers?

Samsung Biologics Co.,Ltd.’s Current Ratio is less than WuXi Biologics (Cayman) Inc. (3.04), greater than Lonza Group AG (1.66), less than WuXi AppTec Co., Ltd. (2.54), less than Asymchem Laboratories (Tianjin) Co., Ltd. (4.56), greater than Pharmaron Beijing Co., Ltd. (1.02), greater than Biocon Limited (1.23), greater than Genscript Biotech Corporation (1.48), less than WuXi XDC Cayman Inc (2.37), greater than Celltrion, Inc. (1.36), greater than Prestige BioPharma Limited (0.75),

Build a custom stock screener for Samsung Biologics Co.,Ltd. (207940.KS) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Samsung Biologics Co.,Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Samsung Biologics Co.,Ltd. (207940.KS) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Samsung Biologics Co.,Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.